Integrin αv and coxsackie adenovirus receptor expression in clinical bladder cancer

被引:111
|
作者
Sachs, MD
Rauen, KA
Ramamurthy, M
Dodson, JL
De Marzo, AM
Putzi, MJ
Schoenberg, MP
Rodriguez, R
机构
[1] Johns Hopkins Univ Hosp, Brady Urol Inst, Baltimore, MD 21287 USA
[2] Humboldt Univ, Charite Med Sch, Dept Urol, Berlin, Germany
[3] Univ Calif San Francisco, Sch Med, Dept Pediat, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Canc Res Inst, Ctr Comprehens Canc, San Francisco, CA 94143 USA
[5] Johns Hopkins Univ Hosp, Dept Surg Pathol, Johns Hopkins Oncol Ctr, Baltimore, MD 21287 USA
关键词
D O I
10.1016/S0090-4295(02)01748-X
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To evaluate the expression of the coxsackie and adenovirus receptor (CAR) and alpha(v) integrins in clinical specimens of bladder cancer to determine the susceptibility to adenoviral gene therapy. Efficient adenovirus-based gene therapy requires binding of the virus to CAR and involves the alpha(v) integrins. Studies on bladder cancer cell lines have shown that low adenoviral transduction rates were associated with low-level expression of CAR. Integrin alpha(v) expression increases in various tumors suggest its importance in differentiation, proliferation, and migration. CAR is structurally a member of the Ig-type superfamily of cell-cell adhesion molecules, suggesting that its expression may also be related to the state of tumor differentiation. Methods. We performed immunohistochemistry for CAR and integrin alpha(v) expression in bladder cancer specimens in 50 paraffin-embedded tumor-normal pairs and confirmed the results by quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) analysis of 11 separate bladder tumors and 4 separate normal bladder controls. Results. Immunochemistry demonstrated a stage and grade-dependent decrease in CAR expression (90.0%, 83.3%, and 31.3% of normal urothelium and superficial and invasive transitional cell carcinoma [TCC] and 83.3% and 39.5% of low and high-grade TCC, respectively). Furthermore, we found a stage and grade-dependent increase in alpha(v) integrin expression (13.3%, 46.0%, and 56.3% of normal urothelium, superficial TCC, and invasive TCC and 25% and 52.6% of low and high-grade TCC, respectively). Quantitative RT-PCR analysis confirmed a downregulation at the CAR gene expression level. Conclusions. This down-regulation may have a major impact on developing adenoviral-based gene therapy modalities. In addition, we propose that loss of CAR expression decreases rigid cell adhesion, possibly increasing the migratory potential. Loss of CAR expression correlates with the invasive phenotype in our analysis of bladder cancer. Simultaneously, the finding of increased alpha(v) expression in invasive cancer suggests a pathogenesis that involves heterophilic adhesion and migration of these cells on various extracellular ligands.
引用
收藏
页码:531 / 536
页数:6
相关论文
共 50 条
  • [31] Loss of coxsackie adenovirus receptor expression is associated with bladdder cancer grade, stage and survival
    Matsumoto, K
    Ayala, GE
    Shariat, S
    Rauen, KA
    Li, RL
    Vazina, A
    Lerner, SP
    JOURNAL OF UROLOGY, 2003, 169 (04): : 405 - 405
  • [32] The dual impact of coxsackie and adenovirus receptor expression on human prostate cancer gene therapy
    Okegawa, T
    Li, YM
    Pong, RC
    Bergelson, JM
    Zhou, J
    Hsieh, JT
    CANCER RESEARCH, 2000, 60 (18) : 5031 - 5036
  • [33] Increased adenoviral transduction efficacy in human laryngeal carcinoma cells resistant to cisplatin is associated with increased expression of integrin αvβ3 and coxsackie adenovirus receptor
    Ambriovic-Ristov, A
    Gabrilovac, J
    Cimbora-Zovko, T
    Osmak, M
    INTERNATIONAL JOURNAL OF CANCER, 2004, 110 (05) : 660 - 667
  • [34] The clinical importance of the soluble splice variants of the Coxsackie adenovirus receptor (CAR) in ovarian cancer
    Reimer, D.
    Steppan, I
    Wiedemair, A.
    Auer, D.
    Marth, C.
    Zeimet, A. G.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2007, 67 (05) : 505 - 505
  • [35] Expression of the coxsackie and adenovirus receptor in human astrocytic tumors and xenografts
    Fuxe, J
    Liu, L
    Malin, S
    Philipson, L
    Collins, VP
    Pettersson, RF
    INTERNATIONAL JOURNAL OF CANCER, 2003, 103 (06) : 723 - 729
  • [36] Coxsackie and Adenovirus receptor (CAR) mRNA expression in human cardiomyopathies
    Sasse, AS
    Wallich, ME
    Ding, ZP
    Goedecke, A
    Schotten, U
    Schrader, J
    CIRCULATION, 2001, 104 (17) : 37 - 37
  • [37] Expression of a human Coxsackie/adenovirus receptor transgene permits adenovirus infection of primary lymphocytes
    Schmidt, MR
    Piekos, B
    Cabatingan, MS
    Woodland, RT
    JOURNAL OF IMMUNOLOGY, 2000, 165 (07): : 4112 - 4119
  • [38] Rejection of adenovirus infection is independent of coxsackie and adenovirus receptor expression in cisplatin-resistant human lung cancer cells
    Zhang, Nian-Hua
    Peng, Rui-Qing
    Ding, Ya
    Zhang, Xiao-Shi
    ONCOLOGY REPORTS, 2016, 36 (02) : 715 - 720
  • [39] Loss of the coxsackie and adenovirus receptor contributes to gastric cancer progression
    Anders, M.
    Vieth, M.
    Roecken, C.
    Ebert, M.
    Pross, M.
    Gretschel, S.
    Schlag, P. M.
    Wiedenmann, B.
    Kemmner, W.
    Hoecker, M.
    BRITISH JOURNAL OF CANCER, 2009, 100 (02) : 352 - 359
  • [40] Loss of the coxsackie and adenovirus receptor contributes to gastric cancer progression
    M Anders
    M Vieth
    C Röcken
    M Ebert
    M Pross
    S Gretschel
    P M Schlag
    B Wiedenmann
    W Kemmner
    M Höcker
    British Journal of Cancer, 2009, 100 : 352 - 359